COMMUNIQUÉS West-GlobeNewswire

Kura Oncology to Present at H.C. Wainwright Global Investment Conference
30/08/2018
SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Idera Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
EXTON, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]
Avadel Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference
30/08/2018
DUBLIN, Ireland, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, today [...]
Translate Bio to Participate in Citi’s 13th Annual Biotech Conference
30/08/2018
LEXINGTON, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
The Joint Corp. to Participate at the Lake Street Capital Markets 2018 Annual Best Ideas Growth Conference
30/08/2018
SCOTTSDALE, Ariz., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced management is scheduled to attend the Lake Street [...]
Sunesis Pharmaceuticals to Present at the Wells Fargo Securities 2018 Healthcare Conference
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
30/08/2018
THE WOODLANDS, Texas, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
RedHill Biopharma Reports Second Quarter 2018 Financial Results and Provides Update on Operations
30/08/2018
Key Highlights: Top-line results from confirmatory Phase III study with TALICIA ® for H. pylori infection on track to be announced in the fourth quarter of 2018 Positive top-line results from Phase III study with RHB- [...]
Antares Pharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
30/08/2018
EWING, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Rodman & Renshaw 20 th Annual [...]
Merus to Participate in Citi’s 13th Annual Biotech Conference
30/08/2018
UTRECHT, The Netherlands, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]
CRISPR Therapeutics to Present at Upcoming Investor Conferences
30/08/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Tonix Pharmaceuticals to Present at Upcoming September Investor Conferences
30/08/2018
NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present a company [...]
VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis
30/08/2018
These data, together with positive preclinical NASH data previously presented, support the potential of VBL’s lecinoxoid pipeline Recently granted US patent provides patent protection for lecinoxoids treatment of [...]
ChromaDex Announces Participation at The 20th Annual Global Investment Conference in New York City September 5, 2018
30/08/2018
IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]
Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm
30/08/2018
Nasdaq Stockholm’s Listing Committee has approved the admission of Infant Bacterial Therapeutics AB’s (“IBT” or the “Company”) shares of series B for trading on the main market of Nasdaq Stockholm. The approval is [...]
Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.
30/08/2018
Press release Malmö, August 30, 2018 Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease. Acarix AB (publ) ("Acarix"), [...]
LIDDS Delårsrapport april-juni 2018
30/08/2018
ANDRA KVARTALET (APRIL - JUNI 2018) Nettoomsättningen uppgick till 0,0 (0,4) MSEK Kostnaderna uppgick till 2,2 (1,6) MSEK Resultatet före och efter skatt uppgick till -2,2 (-1,2) MSEK Resultat per aktie uppgick till -0, [...]
Notification from Oasmia Pharmaceutical AB
30/08/2018
Oasmia Pharmaceutical AB hereby issues a notification that the Company’s loan from Nexttobe AB has according to earlier communication been overtaken by a consortium. Due date for the loan is September 30 th 2019. Notes [...]
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula
30/08/2018
Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 30 Aug 2018 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]

Pages